SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    IOM (Institute of Medicine). Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press; 2000.
  • 2
    Young VR, Newberne PM. Vitamins and cancer prevention: issues and dilemmas. Cancer. 1981;47:122640.
  • 3
    Block G, Levine M, Vitamin C. A new look. Ann Intern Med. 1991;114:90910.
  • 4
    Blumberg J, Heber D. Multivitamins & Public Health: Exploring the Evidence. Summary Statement From Multivitamins & Public Health: Exploring the Evidence; October 1, 2003. Washington, DC: BioScience Communications; 2004.
  • 5
    Shekelle P, Coulter I, Hardy M, et al. Effect of Supplemental Antioxidants Vitamin C, Vitamin E, and Coenzyme Q10 for the Prevention and Treatment of Cardiovascular Disease. Evidence Report/Technology Assessment No. 83 (Prepared by Southern California–RAND Evidence-Based Practice Center, Under Contract No. 290-97-0001). AHRQ Publication No. 03-E043.. Rockville, MD: Agency for Healthcare Research and Quality; 2003. Available at: http://www.ahrq.gov/downloads/pub/evidence/pdf/antioxcan/antioxcan.pdf.
  • 6
    Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:40812.
  • 7
    Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:112.
  • 8
    Moher D, Pham B, Jones A, et al. Does the poor quality of reports of randomized trials exaggerate estimates of intervention effectiveness reported in meta-analyses. Lancet. 1998;352:60913.
  • 9
    Microsoft Corporation Microsoft Excel for Windows 2000. Redmond, WA: Microsoft Corporation; 2000.
  • 10
    Stata Corporation Stata Statistical Software: Release 6.0. Ver. 6.0. College Station, TX: Stata Corporation; 1999.
  • 11
    Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effects of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:102935.
  • 12
    Li J, Taylor P, Li B, et al. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst. 1993;85:14928.
  • 13
    Blot W, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993;85:148392.
  • 14
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:17788.
  • 15
    Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. San Diego, CA: Academic Press Inc.; 1985.
  • 16
    Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088101.
  • 17
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:62934.
  • 18
    Li B, Taylor PR, Li JY, et al. Linxian nutrition intervention trials: design, methods, participant characteristics, and compliance. Ann Epidemiol. 1993;3:57785.
  • 19
    Taylor PR, Li B, Dawsey SM, et al. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group. Cancer Res. 1994;54:2029s31s.
  • 20
    Albanes D, Virtamo J, Rautalahti M, et al. Pilot study: the US-Finland lung cancer prevention trial. J Nutr Growth Cancer. 1986;3:20714.
  • 21
    Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst. 1996;88:156070.
  • 22
    Albanes D, Malila N, Taylor PR, et al. Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland). Cancer Causes Control. 2000;11:197205.
  • 23
    Blot W. Preventing cancer by disrupting progression of precancerous lesions. J Natl Cancer Inst. 2000;92:18689.
  • 24
    Creagan ET, Moertel CG, O'Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med. 1979;301:68790.
  • 25
    Creagan ET, Moertel CG, Schutt AJ, Oconnell MJ. Vitamin-c (ascorbic-acid) therapy of pre-terminal cancer-patients. 1979;20:3556.
  • 26
    Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer. 1998;82:395402.
  • 27
    Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90:4145.
  • 28
    Lamm D, Riggs DR, Shriver JS, VanGilder PF, Rach JF, DeHaven JI. Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol. 1994;151:216.
  • 29
    Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med. 1985;312:13741.
  • 30
    MRC/BHF Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:2333.
  • 31
    Ascorbic acid does not cure cancer. Nutr Rev. 1985;43:1467.
  • 32
    Poulter JM, White WF, Dickerson JW. Ascorbic acid supplementation and five year survival rates in women with early breast cancer. Acta Vitaminol Enzymol. 1984;6:17582.
  • 33
    Rautalahti MT, Virtamo JR, Taylor PR, et al. The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. Cancer. 1999;86:3742.
  • 34
    Virtamo J, Edwards BK, Virtanen M, et al. Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland). Cancer Causes Control. 2000;11:9339.
  • 35
    Dawsey SM, Wang GQ, Taylor PR, et al. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the Dysplasia Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev. 1994;3:16772.
  • 36
    Varis K, Taylor PR, Sipponen P, et al. Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. Scand J Gastroenterol. 1998;33:294300.
  • 37
    Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med. 1994;331:1417.
  • 38
    McKeown-Eyssen G, Holloway C, Jazmaji V, Bright-See E, Dion P, Bruce WR. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res. 1988;48:47015.
  • 39
    Hofstad B, Almendingen K, Vatn M, et al. Growth and recurrence of colorectal polyps: a double-blind, three-year intervention with calcium and antioxidants. Digestion. 1998;59:14856.
  • 40
    Roncucci L, Di Donato P, Carati L, et al. Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16. Dis Colon Rectum. 1993;36:22734.
  • 41
    Roncucci L, Ponz de Leon M. Antioxidant vitamins or lactulose as chemopreventive agents for colorectal cancer. In: WaldronK, JohnsonI, FenwickG, eds. Food and Cancer Prevention: Chemical and Biological Aspects. Cambridge, UK: Royal Society of Cambridge; 1993:14750.
  • 42
    Bussey HJ, DeCosse JJ, Deschner EE, et al. A randomized trial of ascorbic acid in polyposis coli. Cancer. 1982;50:14349.
  • 43
    Cahill RJ, O'Sullivan KR, Mathias PM, Beattie S, Hamilton H, O'Morain C. Effects of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps. Gut. 1993;34:9637.
  • 44
    Malila N, Virtamo J, Virtanen M, Albanes D, Tangrea JA, Huttunen JK. The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev. 1999;8:48993.
  • 45
    Lonn E, Bosch J, Yusuf S, et al. HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293:133847.
  • 46
    Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the women's health study: a randomized controlled trial. JAMA. 2005;294:5665.